Signaling by carcinogenic metals and metal-induced reactive oxygen species

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 533, Issue 1-2, 2003, Pages 183-200

  Harris, Gabriel Keith ^a   Shi, Xianglin ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Metals; Reactive oxygen species; Signal transduction

Indexed keywords

CARCINOGEN; GROWTH FACTOR RECEPTOR; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; METAL; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; PROTEIN TYROSINE KINASE; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT;

CARCINOGENESIS; CARCINOMA; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0344845144     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.08.025     Document Type: Review

References (203)

1. EPA: Health Assessment Document for Cadmium, US Environmental Protection Agency, Washington, DC, 1981.
2. EPA: Evaluation of the Potential Carcinogenicity of Lead and Lead Compounds, US Environmental Protection Agency, Washington, DC, 1989.
3. EPA: Integrated Risk Information System on Beryllium, US Environmental Protection Agency, Washington, DC, 1999.
4. NTP National Toxicology Program Report on Carcinogens, US Department of Health and Human Services, Public Health Service, 2002.
5. Fu H., Boffetta P. Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup. Environ. Med. 52:1995;73-81.
6. Steenland K., Loomis D., Shy C., Simonsen N. Review of occupational lung carcinogens. Am. J. Ind. Med. 29:1996;474-490.
7. Tuchsen F., Jensen M.V., Villadsen E., Lynge E. Incidence of lung cancer among cobalt-exposed women. Scand. J. Work Environ. Health. 22:1996;444-450.
8. Toxic effects of metals, in: C.D. Klaassen (Ed.), Casarett and O'Doul's Toxicology: The Basic Science of Poisons, McGraw-Hill, New York, 1996, pp. 691-736.
9. Desurmont M. Carcinogenic effect of metals. Sem. Hop. 59:1983;2097-2099.
10. Mahata J., Basu A., Ghoshal S., Sarkar J.N., Roy A.K., Poddar G., Nandy A.K., Banerjee A., Ray K., Natarajan A.T., Nilsson R., Giri A.K. Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat. Res. 534:2003;133-143.
11. Hopenhayn-Rich C., Biggs M.L., Smith A.H. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 27:1998;561-569.
12. Agudo A., Ahrens W., Benhamou E., Benhamou S., Boffetta P., Darby S.C., Forastiere F., Fortes C., Gaboriau V., Gonzalez C.A., Jockel K.H., Kreuzer M., Merletti F., Pohlabeln H., Richiardi L., Whitley E., Wichmann H.E., Zambon P., Simonato L. Lung cancer and cigarette smoking in women: a multicenter case-control study in Europe. Int. J. Cancer. 88:2000;820-827.
13. Langard S. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 17:1990;189-215.
14. Balamurugan K., Rajaram R., Ramasami T., Narayanan S. Chromium(III)-induced apoptosis of lymphocytes: death decision by ros and src-family tyrosine kinases. Free Radic. Biol. Med. 33:2002;1622-1640.
15. Drobna Z., Jaspers I., Thomas D.J., Styblo M. Differential activation of ap-1 in human bladder epithelial cells by inorganic and methylated arsenicals. FASEB J. 17:2003;67-69.
16. Simeonova P.P., Wang S., Kashon M.L., Kommineni C., Crecelius E., Luster M.I. Quantitative relationship between arsenic exposure and AP-1 activity in mouse urinary bladder epithelium. Toxicol. Sci. 60:2001;279-284.
17. Filippova M., Duerksen-Hughes P.J. Inorganic and dimethylated arsenic species induce cellular p53. Chem. Res. Toxicol. 16:2003;423-431.
18. Kasprzak K.S. Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis. Free Radic. Biol. Med. 32:2002;958-967.
19. Hartwig A., Schwerdtle T. Interactions by carcinogenic metal compounds with DNA repair processes: toxicological implications. Toxicol. Lett. 127:2002;47-54.
20. Hartwig A., Asmuss M., Ehleben I., Herzer U., Kostelac D., Pelzer A., Schwerdtle T., Burkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ. Health Perspect. 110(Suppl. 5):2002;797-799.
21. Hengstler J.G., Bolm-Audorff U., Faldum A., Janssen K., Reifenrath M., Gotte W., Jung D., Mayer-Popken O., Fuchs J., Gebhard S., Bienfait H.G., Schlink K., Dietrich C., Faust D., Epe B., Oesch F. Occupational exposure to heavy metals: DNA damage induction and DNA repair inhibition prove co-exposures to cadmium, cobalt and lead as more dangerous than hitherto expected. Carcinogenesis. 24:2003;63-73.
22. Bal W., Kasprzak K.S. Induction of oxidative DNA damage by carcinogenic metals. Toxicol. Lett. 127:2002;55-62.
23. Buzard G.S., Kasprzak K.S. Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis: a review. J. Environ. Pathol. Toxicol. Oncol. 19:2000;179-199.
24. Chen F., Shi X. Intracellular signal transduction of cells in response to carcinogenic metals. Crit. Rev. Oncol. Hematol. 42:2002;105-121.
25. Chen F., Ding M., Castranova V., Shi X. Carcinogenic metals and nf-kappab activation. Mol. Cell Biochem. 222:2001;159-171.
26. Meplan C., Richard M.J., Hainaut P. Redox signalling and transition metals in the control of the p53 pathway. Biochem. Pharmacol. 59:2000;25-33.
27. Liu X.H., Kirschenbaum A., Yao S., Stearns M.E., Holland J.F., Claffey K., Levine A.C. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin. Exp. Metastasis. 17:1999;687-694.
28. Baldwin A.S. Jr. The NF-kappa B and I-kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-683.
29. Salnikow K., Gao M., Voitkun V., Huang X., Costa M. Altered oxidative stress responses in nickel-resistant mammalian cells. Cancer Res. 54:1994;6407-6412.
30. Misra U.K., Gawdi G., Pizzo S.V. Beryllium fluoride-induced cell proliferation: a process requiring p21(ras)-dependent activated signal transduction and NF-kappab-dependent gene regulation. J. Leukoc. Biol. 71:2002;487-494.
31. Simeonova P.P., Luster M.I. Arsenic carcinogenicity: relevance of c-src activation. Mol. Cell Biochem. 234-235:2002;277-282.
32. Simeonova P.P., Wang S., Hulderman T., Luster M.I. C-src-dependent activation of the epidermal growth factor receptor and mitogen-activated protein kinase pathway by arsenic. Role in carcinogenesis. J. Biol. Chem. 277:2002;2945-2950.
33. Gibson S., Widmann C., Johnson G.L. Differential involvement of mek kinase 1 (mekk1) in the induction of apoptosis in response to microtubule-targeted drugs versus DNA damaging agents. J. Biol. Chem. 274:1999;10916-10922.
34. Schaeffer H.J., Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:1999;2435-2444.
35. Chen F., Shi X. Signaling from toxic metals to NF-kappa B and beyond: not just a matter of reactive oxygen species. Environ. Health Perspect. 110(Suppl. 5):2002;807-811.
36. Drevs J., Medinger M., Schmidt-Gersbach C., Weber R., Unger C. Receptor tyrosine kinases: the main targets for new anticancer therapy. Curr. Drug Targets. 4:2003;113-121.
37. Nowak A.K., Lake R.A., Kindler H.L., Robinson B.W. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin. Oncol. 29:2002;82-96.
38. Zhang P., Gao W.Y., Turner S., Ducatman B.S. Gleevec (sti-571) inhibits lung cancer cell growth (a549) and potentiates the cisplatin effect in vitro. Mol. Cancer. 2:2003;1.
39. Franklin W.A., Veve R., Hirsch F.R., Helfrich B.A., Bunn P.A. Jr. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin. Oncol. 29:2002;3-14.
40. Kim E.S., Khuri F.R., Herbst R.S. Epidermal growth factor receptor biology (IMC-c225). Curr. Opin. Oncol. 13:2001;506-513.
41. Wells A., Kassis J., Solava J., Turner T., Lauffenburger D.A. Growth factor-induced cell motility in tumor invasion. Acta Oncol. 41:2002;124-130.
42. Wu W., Graves L.M., Jaspers I., Devlin R.B., Reed W., Samet J.M. Activation of the EGF receptor signaling pathway in human airway epithelial cells exposed to metals. Am. J. Physiol. 277:1999;L924-L931.
43. Wu W., Jaspers I., Zhang W., Graves L.M., Samet J.M. Role of ras in metal-induced EGF receptor signaling and NF-kappab activation in human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 282:2002;L1040-L1048.
44. Mollerup S., Rivedal E., Moehle L., Haugen A. Nickel(II) induces alterations in EGF- and TGF-beta 1-mediated growth control during malignant transformation of human kidney epithelial cells. Carcinogenesis. 17:1996;361-367.
45. Namiki A., Brogi E., Kearney M., Kim E.A., Wu T., Couffinhal T., Varticovski L., Isner J.M. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 270:1995;31189-31195.
46. Shweiki D., Neeman M., Itin A., Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 92:1995;768-772.
47. Parast C.V., Mroczkowski B., Pinko C., Misialek S., Khambatta G., Appelt K. Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis. Biochemistry. 37:1998;16788-16801.
48. Duyndam M.C., Hulscher S.T., van der Wall E., Pinedo H.M., Boven E. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. J. Biol. Chem. 278:2003;6885-6895.
49. Moolenaar W.H., Defize L.H., De Laat S.W. Ionic signalling by growth factor receptors. J. Exp. Biol. 124:1986;359-373.
50. + or pH in coronary endothelial cells. Exp. Cell Res. 192:1991;22-31.
51. Lyu R.M., Smith J.B. Genistein inhibits calcium release by platelet-derived growth factor but not bradykinin or cadmium in human fibroblasts. Cell Biol. Toxicol. 9:1993;141-148.
52. 2+ mobilization in hepatocytes. Biochem. J. 339:1999;555-561.
53. George D. Platelet-derived growth factor receptors: a therapeutic target in solid tumors. Semin. Oncol. 28:2001;27-33.
54. Vignaud J.M., Marie B., Klein N., Plenat F., Pech M., Borrelly J., Martinet N., Duprez A., Martinet Y. The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer. Cancer Res. 54:1994;5455-5463.
55. Kataki A., Scheid P., Piet M., Marie B., Martinet N., Martinet Y., Vignaud J.M. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J. Lab. Clin. Med. 140:2002;320-328.
56. Kuwabara K., Ogawa S., Matsumoto M., Koga S., Clauss M., Pinsky D.J., Lyn P., Leavy J., Witte L., Joseph-Silverstein J. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4606-4610.
57. Yurkow E.J., Kim G. Effects of chromium on basal and insulin-induced tyrosine phosphorylation in H4 hepatoma cells: comparison with phorbol-12-myristate-13-acetate and sodium orthovanadate. Mol. Pharmacol. 47:1995;686-695.
58. Witmer C., Faria E., Park H.S., Sadrieh N., Yurkow E., O'Connell S., Sirak A., Schleyer H. In vivo effects of chromium. Environ. Health Perspect. 102(Suppl. 3):1994;169-176.
59. Shapiro P. Ras-map kinase signaling pathways and control of cell proliferation: relevance to cancer therapy. Crit. Rev. Clin. Lab. Sci. 39:2002;285-330.
60. Vachtenheim J. Occurrence of ras mutations in human lung cancer. Minirev. Neoplasma. 44:1997;145-149.
61. Macaluso M., Russo G., Cinti C., Bazan V., Gebbia N., Russo A. Ras family genes: an interesting link between cell cycle and cancer. J. Cell Physiol. 192:2002;125-130.
62. Ding M., Shi X., Castranova V., Vallyathan V. Predisposing factors in occupational lung cancer: inorganic minerals and chromium. J. Environ. Pathol. Toxicol. Oncol. 19:2000;129-138.
63. Wei M., Wanibuchi H., Morimura K., Iwai S., Yoshida K., Endo G., Nakae D., Fukushima S. Carcinogenicity of dimethylarsinic acid in male f344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis. 23:2002;1387-1397.
64. Higinbotham K.G., Rice J.M., Diwan B.A., Kasprzak K.S., Reed C.D., Perantoni A.O. GGT to GTT transversions in codon 12 of the K-ras oncogene in rat renal sarcomas induced with nickel subsulfide or nickel subsulfide/iron are consistent with oxidative damage to DNA. Cancer Res. 52:1992;4747-4751.
65. Scobbie A.E., Aw T.C. Measurement of ras p21 in urine of people occupationally exposed to chromium compounds. Occup. Environ. Med. 52:1995;556.
66. Scobbie A.E., Anderson J.B., Horwich A. Measurement of ras p21 in the urine of patients with urological tumours. In Vivo. 8:1994;1067-1072.
67. Scobbie A., Anderson J.B., Horwich A. Detection of activated ras p21 in urine samples associated with bladder and prostate cancer. J. Occup. Med. 36:1994;298-299.
68. Frame M.C. Src in cancer: deregulation and consequences for cell behaviour. Biochim. Biophys. Acta. 1602:2002;114-130.
69. Jones R.J., Brunton V.G., Frame M.C. Adhesion-linked kinases in cancer emphasis on src, focal adhesion kinase and PI 3-kinase. Eur. J. Cancer. 36:2000;1595-1606.
70. Samet J.M., Graves L.M., Quay J., Dailey L.A., Devlin R.B. Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am. J. Physiol. 275:1998;L551-558.
71. Chen F., Lu Y., Zhang Z., Vallyathan V., Ding M., Castranova V., Shi X. Opposite effect of NF-kappa B and C-jun N-terminal kinase on p53-independent GADD45 induction by arsenite. J. Biol. Chem. 276:2001;11414-11419.
72. Huang C., Ma W.Y., Li J., Dong Z. Arsenic induces apoptosis through a C-jun NH2-terminal kinase-dependent, p53-independent pathway. Cancer Res. 59:1999;3053-3058.
73. Elbirt K.K., Whitmarsh A.J., Davis R.J., Bonkovsky H.L. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells. Role of mitogen-activated protein kinases. J. Biol. Chem. 273:1998;8922-8931.
74. Iryo Y., Matsuoka M., Wispriyono B., Sugiura T., Igisu H. Involvement of the extracellular signal-regulated protein kinase (ERK) pathway in the induction of apoptosis by cadmium chloride in CCRF-CEM cells. Biochem. Pharmacol. 60:2000;1875-1882.
75. Chuang S.M., Yang J.L. Comparison of roles of three mitogen-activated protein kinases induced by chromium(VI) and cadmium in non-small-cell lung carcinoma cells. Mol. Cell Biochem. 222:2001;85-95.
76. Alam J., Wicks C., Stewart D., Gong P., Touchard C., Otterbein S., Choi A.M., Burrow M.E., Tou J. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and NRF2 transcription factor. J. Biol. Chem. 275:2000;27694-27702.
77. Abe J., Kusuhara M., Ulevitch R.J., Berk B.C., Lee J.D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J. Biol. Chem. 271:1996;16586-16590.
78. Pumiglia K., Chow Y.H., Fabian J., Morrison D., Decker S., Jove R. Raf-1 n-terminal sequences necessary for ras-raf interaction and signal transduction. Mol. Cell. Biol. 15:1995;398-406.
79. van Blitterswijk W.J., Houssa B. Diacylglycerol kinases in signal transduction. Chem. Phys. Lipids. 98:1999;95-108.
80. Sunderman F.W. Jr., Barber A.M. Finger-loops, oncogenes, and metals. Claude Passmore Brown memorial lecture. Ann. Clin. Lab. Sci. 18:1988;267-288.
81. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70.
82. D.C. Guttridge, C. Albanese, J.Y. Reuther, R.G. Pestell, A.S. Baldwin Jr., NF-kappa B controls cell growth and differentiation through transcriptional regulation of cyclin d1, Mol. Cell. Biol. 19 (1999) 5785-5799.
83. Mayo M.W., Norris J.L., Baldwin A.S. Ras regulation of NF-kappa B and apoptosis. Methods Enzymol. 333:2001;73-87.
84. Jin R., De Smaele E., Zazzeroni F., Nguyen D.U., Papa S., Jones J., Cox C., Gelinas C., Franzoso G. Regulation of the GADD45beta promoter by NF-kappa B. DNA Cell Biol. 21:2002;491-503.
85. Heckman C.A., Mehew J.W., Boxer L.M. NF-kappa B activates bcl-2 expression in T(1418) lymphoma cells. Oncogene. 21:2002;3898-3908.
86. Yamamoto K., Arakawa T., Ueda N., Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270:1995;31315-31320.
87. La Rosa F.A., Pierce J.W., Sonenshein G.E. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors. Mol. Cell. Biol. 14:1994;1039-1044.
88. Mathas S., Lietz A., Janz M., Hinz M., Jundt F., Scheideret C., Bommert K., Doerken B. Inhibition of NF-kappa B essentially contributes to arsenic-induced apoptosis. Blood. 3:2003;3.
89. Dong Z. The molecular mechanisms of arsenic-induced cell transformation and apoptosis. Environ. Health Perspect. 110(Suppl. 5):2002;757-759.
90. Huang C., Li J., Ding M., Wang L., Shi X., Castranova V., Ju G., Costa M., Dong Z. Arsenic-induced NFkappa B transactivation through ERKs- and JNKs-dependent pathways in mouse epidermal JB6 cells. Mol. Cell Biochem. 222:2001;29-34.
91. Wijeweera J.B., Gandolfi A.J., Parrish A., Lantz R.C. Sodium arsenite enhances AP-1 and NFkappa B DNA binding and induces stress protein expression in precision-cut rat lung slices. Toxicol. Sci. 61:2001;283-294.
92. Li M., Cai J.F., Chiu J.F. Arsenic induces oxidative stress and activates stress gene expressions in cultured lung epithelial cells. J. Cell Biochem. 87:2002;29-38.
93. Hu Y., Jin X., Snow E.T. Effect of arsenic on transcription factor AP-1 and NF-kappa B DNA binding activity and related gene expression. Toxicol. Lett. 133:2002;33-45.
94. Huang Y., Davidson G., Li J., Yan Y., Chen F., Costa M., Chen L.C., Huang C. Activation of nuclear factor-kappa B and not activator protein-1 in cellular response to nickel compounds. Environ. Health Perspect. 110(Suppl. 5):2002;835-839.
95. Goebeler M., Roth J., Brocker E.B., Sorg C., Schulze-Osthoff K. Activation of nuclear factor-kappa B and gene expression in human endothelial cells by the common haptens nickel and cobalt. J. Immunol. 155:1995;2459-2467.
96. Misra U.K., Gawdi G., Akabani G., Pizzo S.V. Cadmium-induced DNA synthesis and cell proliferation in macrophages: the role of intracellular calcium and signal transduction mechanisms. Cell Signal. 14:2002;327-340.
97. 4+ T lymphocytes. Biochem. Biophys. Res. Commun. 227:1996;380-385.
98. Lin M., Rippe R.A., Niemela O., Brittenham G., Tsukamoto H. Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am. J. Physiol. 272:1997;G1355-G1364.
99. Wisdom R. AP-1: one switch for many signals. Exp. Cell Res. 253:1999;180-185.
100. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:1995;16483-16486.
101. Pramanik R., Qi X., Borowicz S., Choubey D., Schultz R.M., Han J., Chen G. p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-jun, the determinant roles of the isoforms in the p38 MAPK signal specificity. J. Biol. Chem. 278:2003;4831-4839.
102. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:2002;E131-136.
103. Shaulian E., Karin M. AP-1 in cell proliferation and survival. Oncogene. 20:2001;2390-2400.
104. Simeonova P.P., Wang S., Toriuma W., Kommineni V., Matheson J., Unimye N., Kayama F., Harki D., Vallyathan V., Luster M.I. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res. 60:2000;3445-3453.
105. Huang C., Bode A.M., Chen N.Y., Ma W.Y., Li J., Nomura M., Dong Z. Transactivation of AP-1 in AP-1-luciferase reporter transgenic mice by arsenite and arsenate. Anticancer Res. 21:2001;261-267.
106. Chen N.Y., Ma W.Y., Huang C., Ding M., Dong Z. Activation of PKC is required for arsenite-induced signal transduction. J. Environ. Pathol. Toxicol. Oncol. 19:2000;297-305.
107. Chen F., Ding M., Lu Y., Leonard S.S., Vallyathan V., Castranova V., Shi X. Participation of MAP kinase p38 and Ikappab kinase in chromium(VI)-induced NF-kappa B and AP-1 activation. J. Environ. Pathol. Toxicol. Oncol. 19:2000;231-238.
108. Andrew A.S., Klei L.R., Barchowsky A. AP-1-dependent induction of plasminogen activator inhibitor-1 by nickel does not require reactive oxygen. Am. J. Physiol. Lung Cell Mol. Physiol. 281:2001;L616-L623.
109. Joseph P., Muchnok T.K., Klishis M.L., Roberts J.R., Antonini J.M., Whong W.Z., Ong T. Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species. Toxicol. Sci. 61:2001;295-303.
110. Huang C., Zhang Q., Li J., Shi X., Castranova V., Ju G., Costa M., Dong Z. Involvement of ERKs activation in cadmium-induced AP-1 transactivation in vitro and in vivo. Mol. Cell Biochem. 222:2001;141-147.
111. Kim K.A., Chakraborti T., Goldstein G.W., Bressler J.P. Immediate early gene expression in PC12 cells exposed to lead: requirement for protein kinase C. J. Neurochem. 74:2000;1140-1146.
112. Ramesh G.T., Manna S.K., Aggarwal B.B., Jadhav A.L. Lead activates nuclear transcription factor-kappa B, activator protein-1, and amino-terminal c-jun kinase in pheochromocytoma cells. Toxicol. Appl. Pharmacol. 155:1999;280-286.
113. Zou W., Yan M., Xu W., Huo H., Sun L., Zheng Z., Liu X. Cobalt chloride induces PC12 cells apoptosis through reactive oxygen species and accompanied by AP-1 activation. J. Neurosci. Res. 64:2001;646-653.
114. Huang C., Li J., Zhang Q., Huang X. Role of bioavailable iron in coal dust-induced activation of activator protein-1 and nuclear factor of activated T cells: difference between Pennsylvania and Utah coal dusts. Am. J. Respir. Cell Mol. Biol. 27:2002;568-574.
115. Rao A., Luo C., Hogan P. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:1997;707-747.
116. Parsons S.A., Wilkins B.J., Bueno O.F., Molkentin J.D. Altered skeletal muscle phenotypes in calcineurin A and A-beta gene-targeted mice. Mol. Cell. Biol. 23:2003;4331-4343.
117. Horsley V., Pavlath G.K. Prostaglandin F2-alpha stimulates growth of skeletal muscle cells via an NFATc2-dependent pathway. J. Cell Biol. 161:2003;111-118.
118. Tomita M., Reinhold M.I., Molkentin J.D., Naski M.C. Calcineurin and NFAT4 induce chondrogenesis. J. Biol. Chem. 277:2002;42214-42218.
119. 2+/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell. 105:2001;863-875.
120. Friday B.B., Horsley V., Pavlath G.K. Calcineurin activity is required for the initiation of skeletal muscle differentiation. J. Cell Biol. 149:2000;657-666.
121. Ranger A.M., Gerstenfeld L.C., Wang J., Kon T., Bae H., Gravallese E.M., Glimcher M.J., Glimcher L.H. The nuclear factor of activated t cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J. Exp. Med. 191:2000;9-22.
122. Macian F., Lopez-Rodriguez C., Rao A. Partners in transcription: NFAT and AP-1. Oncogene. 20:2001;2476-2489.
123. Macian F., Rao A. Reciprocal modulatory interaction between human immunodeficiency virus type 1 TAT and transcription factor NFAT1. Mol. Cell. Biol. 19:1999;3645-3653.
124. Huang C., Ding M., Li J., Leonard S.S., Rojanasakul Y., Castranova V., Vallyathan V., Ju G., Shi X. Vanadium-induced nuclear factor of activated T cells activation through hydrogen peroxide. J. Biol. Chem. 276:2001;22397-22403.
125. Huang C., Li J., Costa M., Zhang Z., Leonard S.S., Castranova V., Vallyathan V., Ju G., Shi X. Hydrogen peroxide mediates activation of nuclear factor of activated T cells (NFAT) by nickel subsulfide. Cancer Res. 61:2001;8051-8057.
126. Salnikow K., Davidson T., Kluz T., Chen H., Zhou D., Costa M. Genechip analysis of signaling pathways effected by nickel. J. Environ. Monit. 5:2003;206-209.
127. Salnikow K., Davidson T., Costa M. The role of hypoxia-inducible signaling pathway in nickel carcinogenesis. Environ. Health Perspect. 110(Suppl. 5):2002;831-834.
128. Sheta E.A., Trout H., Gildea J.J., Harding M.A., Theodorescu D. Cell density mediated pericellular hypoxia leads to induction of HIF-1 alpha via nitric oxide and ras/MAP kinase mediated signaling pathways. Oncogene. 20:2001;7624-7634.
129. Karni R., Dor Y., Keshet E., Meyuhas O., Levitzki A. Activated pp60c-src leads to elevated hypoxia-inducible factor (HIF)-1alpha expression under normoxia. J. Biol. Chem. 277:2002;42919-42925.
130. Gao N., Jiang B.H., Leonard S.S., Corum L., Zhang Z., Roberts J.R., Antonini J., Zheng J.Z., Flynn D.C., Castronova V., Shi X. p38 signaling-mediated hypoxia-inducible factor 1 alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J. Biol. Chem. 277:2002;45041-45048.
131. Costa M., Yan Y., Zhao D., Salnikow K. Molecular mechanisms of nickel carcinogenesis: gene silencing by nickel delivery to the nucleus and gene activation/inactivation by nickel-induced cell signaling. J. Environ. Monit. 5:2003;222-223.
132. Salnikow K., Blagosklonny M.V., Ryan H., Johnson R., Costa M. Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res. 60:2000;38-41.
133. Caamano J., Ruggeri B., Momiki S., Sickler A., Zhang S.Y., Klein-Szanto A.J. Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines. Am. J. Pathol. 139:1991;839-845.
134. Niklinski J., Niklinska W., Laudanski J., Chyczewska E., Chyczewski L. Prognostic molecular markers in non-small cell lung cancer. Lung Cancer. 34(Suppl. 2):2001;S53-S58.
135. Zhan Q., Fan S., Smith M.L., Bae I., Yu K., Alamo I. Jr., O'Connor P.M., Fornace A.J. Jr. Abrogation of p53 function affects GADD gene responses to DNA base-damaging agents and starvation. DNA Cell Biol. 15:1996;805-815.
136. Meplan C., Mann K., Hainaut P. Cadmium induces conformational modifications of wild-type p53 and suppresses p53 response to DNA damage in cultured cells. J. Biol. Chem. 274:1999;31663-31670.
137. Zhu J., Chen Z., Lallemand-Breitenbach V., de The H. How acute promyelocytic leukaemia revived arsenic. Nat. Rev. Cancer. 2:2002;705-713.
138. Bachleitner-Hofmann T., Kees M., Gisslinger H. Arsenic trioxide: acute promyelocytic leukemia and beyond. Leuk. Lymphoma. 43:2002;1535-1540.
139. Liu Q., Hilsenbeck S., Gazitt Y. Arsenic trioxide-induced apoptosis in myeloma cells: P53-dependent G1 or G2/m cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with apo2/trail. Blood. 101:2003;4078-4087.
140. Shi Y., Liu Y., Huo J., Gao G. Arsenic trioxide induced apoptosis and expression of p53 and bcl-2 genes in human small cell lung cancer cells. Zhonghua Jie He He Hu Xi Za Zhi. 25:2002;665-666.
141. Jiang X.H., Wong B.C., Yuen S.T., Jiang S.H., Cho C.H., Lai K.C., Lin M.C., Kung H.F., Lam S.K., Wong B.C.Y. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Int. J. Cancer. 91:2001;173-179.
142. Hsu C.H., Yang S.A., Wang J.Y., Yu H.S., Lin S.R. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Br. J. Cancer. 80:1999;1080-1086.
143. Castren K., Ranki A., Welsh J.A., Vahakangas K.H. Infrequent p53 mutations in arsenic-related skin lesions. Oncol. Res. 10:1998;475-482.
144. Boonchai W., Walsh M., Cummings M., Chenevix-Trench G. Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Arch. Dermatol. 136:2000;195-198.
145. Hamadeh H.K., Vargas M., Lee E., Menzel D.B. Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis. Biochem. Biophys. Res. Commun. 263:1999;446-449.
146. Mass M.J., Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res. 386:1997;263-277.
147. Pernin D., Uhrhammer N., Verrelle P., Bignon Y.J., Bay J.O. p53 activation by PI-3K family kinases after DNA double-strand breaks. Bull. Cancer. 87:2000;635-641.
148. Kondo K., Hino N., Sasa M., Kamamura Y., Sakiyama S., Tsuyuguchi M., Hashimoto M., Uyama T., Monden Y. Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem. Biophys. Res. Commun. 239:1997;95-100.
149. Hanaoka T., Yamano Y., Katsuno N., Kagawa J., Ishizu S. Elevated serum levels of pantropic p53 proteins in chromium workers. Scand. J. Work Environ. Health. 23:1997;37-40.
150. Wang S., Shi X. Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK. Carcinogenesis. 22:2001;757-762.
151. Carlisle D.L., Pritchard D.E., Singh J., Patierno S.R. Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol. Carcinogen. 28:2000;111-118.
152. Feng Z., Hu W., Rom W.N., Costa M., Tang M.S. Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells. Carcinogenesis. 24:2003;771-778.
153. Liu K., Husler J., Ye J., Leonard S.S., Cutler D., Chen F., Wang S., Zhang Z., Ding M., Wang L., Shi X. On the mechanism of Cr(VI)-induced carcinogenesis: dose dependence of uptake and cellular responses. Mol. Cell Biochem. 222:2001;221-229.
154. Wang S., Leonard S.S., Ye J., Ding M., Shi X. The role of hydroxyl radical as a messenger in Cr(VI)-induced p53 activation. Am. J. Physiol. Cell Physiol. 279:2000;C868-C875.
155. Ye J., Wang S., Leonard S.S., Sun Y., Butterworth L., Antonini J., Ding M., Rojanasakul Y., Vallyathan V., Castranova V., Shi X. Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. J. Biol Chem. 274:1999;34974-34980.
156. Shiao Y.H., Lee S.H., Kasprzak K.S. Cell cycle arrest, apoptosis and p53 expression in nickel(II) acetate-treated Chinese hamster ovary cells. Carcinogenesis. 19:1998;1203-1207.
157. Salnikow K., An W.G., Melillo G., Blagosklonny M.V., Costa M. Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis. 20:1999;1819-1823.
158. Maehle L., Metcalf R.A., Ryberg D., Bennett W.P., Harris C.C., Haugen A. Altered p53 gene structure and expression in human epithelial cells after exposure to nickel. Cancer Res. 52:1992;218-221.
159. Zhang Z., Suo Z., Sudbo J., Holm R., Boysen M., Reith A. Diagnostic implications of p53 protein reactivity in nasal mucosa of nickel workers. Anal. Quant. Cytol. Histol. 19:1997;345-350.
160. Finch G.L., March T.H., Hahn F.F., Barr E.B., Belinsky S.A., Hoover M.D., Lechner J.F., Nikula K.J., Hobbs C.H. Carcinogenic responses of transgenic heterozygous p53 knockout mice to inhaled 239puo2 or metallic beryllium. Toxicol. Pathol. 26:1998;484-491.
161. Nickell-Brady C., Hahn F.F., Finch G.L., Belinsky S.A. Analysis of k-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis. 15:1994;257-262.
162. Kim B.J., Kim M.S., Kim K.B., Kim K.W., Hong Y.M., Kim I.K., Lee H.W., Jung Y.K. Sensitizing effects of cadmium on TNF-alpha- and trail-mediated apoptosis of NIH3T3 cells with distinct expression patterns of p53. Carcinogenesis. 23:2002;1411-1417.
163. Lag M., Westly S., Lerstad T., Bjornsrud C., Refsnes M., Schwarze P.E. Cadmium-induced apoptosis of primary epithelial lung cells: involvement of bax and p53, but not of oxidative stress. Cell Biol. Toxicol. 18:2002;29-42.
164. Achanzar W.E., Achanzar K.B., Lewis J.G., Webber M.M., Waalkes M.P. Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. Toxicol. Appl. Pharmacol. 164:2000;291-300.
165. Zhou T., Zhou G., Song W., Eguchi N., Lu W., Lundin E., Jin T., Nordberg G. Cadmium-induced apoptosis and changes in expression of p53, c-jun and MT-I genes in testes and ventral prostate of rats. Toxicology. 142:1999;1-13.
166. Matsuoka M., Igisu H. Cadmium induces phosphorylation of p53 at serine 15 in MCF-7 cells. Biochem. Biophys. Res. Commun. 282:2001;1120-1125.
167. Lee S.G., Lee H., Rho H.M. Transcriptional repression of the human p53 gene by cobalt chloride mimicking hypoxia. FEBS Lett. 507:2001;259-263.
168. Marrogi A.J., Khan M.A., van Gijssel H.E., Welsh J.A., Rahim H., Demetris A.J., Kowdley K.V., Hussain S.P., Nair J., Bartsch H., Okby N., Poirier M.C., Ishak K.G., Harris C.C. Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma. J. Natl. Cancer Inst. 93:2001;1652-1655.
169. Fukuchi K., Tomoyasu S., Watanabe H., Kaetsu S., Tsuruoka N., Gomi K. Iron deprivation results in an increase in p53 expression. Biol. Chem. Hoppe Seyler. 376:1995;627-630.
170. Yang J., Yu Y., Duerksen-Hughes P.J. Protein kinases and their involvement in the cellular responses to genotoxic stress. Mutat. Res. 543:2003;31-58.
171. Kawanishi S., Hiraku Y., Murata M., Oikawa S. The role of metals in site-specific DNA damage with reference to carcinogenesis. Free Radic. Biol. Med. 32:2002;822-832.
172. Yermolaieva O., Brot N., Weissbach H., Heinemann S.H., Hoshi T. Reactive oxygen species and nitric oxide mediate plasticity of neuronal calcium signaling. Proc. Natl. Acad. Sci. U.S.A. 97:2000;448-453.
173. Haddad J.J., Land S.C. Redox/ros regulation of lipopolysaccharide- induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis. Br. J. Pharmacol. 135:2002;520-536.
174. Haddad J.J. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell. Signal. 14:2002;879-897.
175. Lavrovsky Y., Chatterjee B., Clark R.A., Roy A.K. Role of redox-regulated transcription factors in inflammation. Exp. Gerontol. 35:2000;521-532.
176. Maziere C., Conte M.A., Degonville J., Ali D., Maziere J.C. Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP-1 and NFkappa B. Biochem. Biophys. Res. Commun. 265:1999;116-122.
177. Haddad J.J., Land S.C. A non-hypoxic, ros-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett. 505:2001;269-274.
178. Leonard S., Wang S., Zang L., Castranova V., Vallyathan V., Shi X. Role of molecular oxygen in the generation of hydroxyl and superoxide anion radicals during enzymatic Cr(VI) reduction and its implication to Cr(VI)-induced carcinogenesis. J. Environ. Pathol. Toxicol. Oncol. 19:2000;49-60.
179. B.G. Halliwell, J.M.C. Gutteridge, Free Radicals in Biology and Medicine, Oxford University Press, Oxford, 2000.
180. Stohs S.J., Bagchi D., Hassoun E., Bagchi M. Oxidative mechanisms in the toxicity of chromium and cadmium ions. J. Environ. Pathol. Toxicol. Oncol. 20:2001;77-88.
181. Tatrai E., Kovacikova Z., Hudak A., Adamis Z., Ungvary G. Comparative in vitro toxicity of cadmium and lead on redox cycling in type II pneumocytes. J. Appl. Toxicol. 21:2001;479-483.
182. Chuang S.M., Liou G.Y., Yang J.L. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis. 21:2000;1491-1500.
183. Schimmel M., Bauer G. Proapoptotic and redox state-related signaling of reactive oxygen species generated by transformed fibroblasts. Oncogene. 21:2002;5886-5896.
184. Porwol T., Ehleben W., Zierold K., Fandrey J., Acker H. The influence of nickel and cobalt on putative members of the oxygen-sensing pathway of erythropoietin-producing HEPG2 cells. Eur. J. Biochem. 256:1998;16-23.
185. Lloyd D.R., Phillips D.H. Oxidative DNA damage mediated by copper(II), iron(II) and nickel(II) fenton reactions: evidence for site-specific mechanisms in the formation of double-strand breaks, 8-hydroxydeoxyguanosine and putative intrastrand cross-links. Mutat. Res. 424:1999;23-36.
186. Wolin M.S. Interactions of oxidants with vascular signaling systems. Arterioscler. Thromb. Vasc. Biol. 20:2000;1430-1442.
187. Kessel M., Liu S.X., Xu A., Santella R., Hei T.K. Arsenic induces oxidative DNA damage in mammalian cells. Mol. Cell. Biochem. 234-235:2002;301-308.
188. Wu M.M., Chiou H.Y., Wang T.W., Hsueh Y.M., Wang I.H., Chen C.J., Lee T.C. Association of blood arsenic levels with increased reactive oxidants and decreased antioxidant capacity in a human population of northeastern Taiwan. Environ. Health Perspect. 109:2001;1011-1017.
189. Lee D.N., Yen H.T., Shen T.F., Chen B.J. Chromium-induced glucose uptake, superoxide anion production, and phagocytosis in cultured pulmonary alveolar macrophages of weanling pigs. Biol. Trace Elem. Res. 77:2000;53-64.
190. Shainkin-Kestenbaum R., Caruso C., Berlyne G.M. Effect of chromium on oxygen free radical metabolism, inhibition of superoxide dismutase and enhancement of 6-hydroxydopamine oxidation. J. Trace Elem. Electrolyte Health Dis. 5:1991;197-201.
191. Batra N., Nehru B., Bansal M.P. The effect of zinc supplementation on the effects of lead on the rat testis. Reprod. Toxicol. 12:1998;535-540.
192. Matozzo V., Ballarin L., Pampanin D.M., Marin M.G. Effects of copper and cadmium exposure on functional responses of hemocytes in the clam, Tapes philippinarum. Arch. Environ. Contam. Toxicol. 41:2001;163-170.
193. Zhao Y., Xue Y., Oberley T.D., Kiningham K.K., Lin S.M., Yen H.C., Majima H., Hines J., Clair D.St. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 61:2001;6082-6088.
194. Chuang J., Chang T., Liu H. Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin. Oncogene. 22:2003;1349-1357.
195. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic. Biol. Med. 20:1996;553-566.
196. 2 regulates the activation of distinct MAPK pathways. Free Radic. Biol. Med. 33:2002;1121-1132.
197. Forman H.J., Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am. J. Respir. Crit. Care Med. 166:2002;S4-S8.
198. Ding M., Li J., Leonard S.S., Shi X., Costa M., Castranova V., Vallyathan V., Huang C. Differential role of hydrogen peroxide in UV-induced signal transduction. Mol. Cell. Biochem. 234-235:2002;81-90.
199. 2+ in TGF-beta 1-induced IL-6 expression. J. Immunol. 165:2000;2190-2197.
200. Milligan S.A., Owens M.W., Grisham M.B. Differential regulation of extracellular signal-regulated kinase and nuclear factor-kappa B signal transduction pathways by hydrogen peroxide and tumor necrosis factor. Arch. Biochem. Biophys. 352:1998;255-262.
201. Bae D.S., Hanneman W.H., Yang R.S., Campain J.A. Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: application of cDNA microarray technology. Environ. Health Perspect. 110(Suppl. 6):2002;931-941.
202. Chen F., Bower J., Leonard S.S., Ding M., Lu Y., Rojanasakul Y., Kung H.F., Vallyathan V., Castranova V., Shi X. Protective roles of NF-kappa B for chromium(VI)-induced cytotoxicity is revealed by expression of I kappa B kinase-beta mutant. J. Biol. Chem. 277:2002;3342-3349.
203. Ye J., Shi X. Gene expression profile in response to chromium-induced cell stress in A549 cells. Mol. Cell. Biochem. 222:2001;189-197.